Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Guangzhou Hanpu Pharmaceutical is a China-based pharmaceutical manufacturer focused on the research, development, manufacture, and sale of active pharmaceutical ingredients and selected finished dosage forms. The company was founded in 2002 and operates GMP-standard facilities for APIs, solid preparations, and eye drops in Guangzhou. Publicly available product references indicate commercial supply of small-molecule anti-infective and related APIs such as clotrimazole, miconazole nitrate, and methenamine hippurate. Hanpu appears to be primarily a manufacturing and supply company rather than a clinical-stage innovator, with business activity centered on API production, regulatory filings, and pharmaceutical manufacturing services.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Guangzhou Hanpu Pharmaceutical.